Apr 30, 2020 - The combined effort of these two companies marks one of the largest manufacturing collaborations on the planet toward a coronavirus vaccine.
Apr 30, 2020 - Glaxo (GSK) beats on earnings and sales in the first quarter. Strong demand for respiratory drugs and Shingrix along with stockpiling of certain drugs amid COVID-19 drive sales.
Apr 29, 2020 - GSK earnings call for the period ending March 31, 2020.
Apr 29, 2020 -
Apr 29, 2020 - The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Apr 28, 2020 - Strong demand for Glaxo's Trelegy Ellipta is likely to have driven royalties for Innoviva (INVA) in the first quarter.
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
Apr 24, 2020 - Sanofi (SNY) beats estimates for both earnings and sales. Around half of the sales and earnings growth at CER was due to COVID-19 associated patient stockpiling. Stock down.
Apr 24, 2020 - Investors will focus on the HIV franchise's performance along with updates on experimental coronavirus treatment, when Gilead (GILD) reports first-quarter 2020 results.
Apr 24, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the first quarter. Results will provide clarity on the impact of coronavirus on the company's business.